You are here

Susan M. Schneider, PhD, RN, AOCN, ACNS-BC, FAAN

Associate Professor
Phone: 
(919) 684-9240
Office: 
3051 Pearson Building

Dr. Schneider is Associate Professor and serves as faculty lead for the graduate oncology specialty at the School of Nursing. She received her doctorate in nursing from Case Western Reserve University, her Master of Science degree from Texas Woman’s University, and her BSN from the University of Akron. Dr. Schneider has extensive experience in pediatric and adult oncology nursing. She holds certification as a clinical nurse specialist and as an advanced oncology certified nurse.

Prior to joining the faculty at Duke University, Dr. Schneider taught in the oncology program at Frances Payne Bolton School of Nursing at Case Western Reserve University, and was a clinical nurse specialist at University Hospitals of Cleveland. She is professionally active in a number of nursing organizations. She has chaired the American Cancer Society Peer Review Committee on Scholarships and Professorships in Oncology Nursing, served as a member of the Oncology Nursing Society (ONS) national board of directors, and is now President-Elect of the ONS. Dr. Schneider has received both the Excellence in Cancer Nursing Research and Excellence in Cancer Nursing Education Awards from the Oncology Nursing Society and is a Fellow of the American Academy of Nursing.

Dr. Schneider's research interests include management of symptom distress in cancer patients, the use of distraction interventions to enhance coping, and the use of tailored protocols to promote chemotherapy adherence.

Academic Program Affiliations

  • PhD in Nursing Program
  • Master of Science in Nursing Program
  • Doctor of Nursing Practice Program

Education

  • PhD - Case Western Reserve University, Frances Payne Bolton School of Nursing
  • MS - Texas Woman's University
  • BSN - The University of Akron

Research Interests

Dr. Schneider’s research interests include the management of symptom distress in cancer patients and the use of distraction interventions to enhance coping. She has conducted a series of four studies exploring the use of a virtual reality distraction intervention to mitigate chemotherapy related symptom distress in adult and pediatric populations.

Current research includes a randomized clinical trial of a tailored intervention protocol designed to promote adherence to oral chemotherapy in adults receiving treatment for breast or colorectal cancer.

Awards and Honors

  • 2012 || 2012 Award for Excellence, Frances Payne Bolton School of Nursing Alumni Association
  • 2008 || Fellow, American Academy of Nursing
  • 2004 || Mary Nowotny Excellence in Cancer Nursing Education Award, Oncology Nursing Society
  • 2003 || Research Mentorship Award, Friends of Nursing, Duke University
  • 2000 || Inducted, Sigma Theta Tau (Beta Epsilon Chapter)
  • 1998 || Benita Martocchio Excellence in Oncology Nursing
  • 1996 || Pediatric Nursing Dissertation Scholarship
  • 1995 || Clinton E. and Vicki A. Lambert Award for Scholarly Writing
  • 1995 || ONS/NCI Research Short Course Participant, Oncology Nursing Society and National Cancer Institute
  • 1994 || American Cancer Society Doctoral Scholarship
  • 1994 || Oncology Nursing Society Doctoral Scholarship
  • 1981 || Inducted, Sigma Theta Tau

Areas of Expertise

  • Oncology

Representative Publications

  • 2015 -- PubMed # : 26000578 Lassiter, M. and Schneider, S. M. A pilot study comparing the neutropenic diet to a non-neutropenic diet in the allogeneic hematopoietic stem cell transplantation population. Clin J Oncol Nurs. June, 2015 19(3); 273-8
  • 2015 -- PubMed # : 26000590 Smithson, C. R. and Schneider, S. M. Ibrutinib: a new targeted therapy for hematologic cancers. Clin J Oncol Nurs. June, 2015 19(3); E47-51
  • 2014 -- PubMed # : 24570103 Affronti, M. L. and Schneider, S. M. and Herndon 2nd, J. E. and Schlundt, S. and Friedman, H. S. Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice. Support Care Cancer. July, 2014 22(7); 1897-905
  • 2014 -- PubMed # : 25089216 Schneider, S. M. and Adams, D. B. and Gosselin, T. A tailored nurse coaching intervention for oral chemotherapy adherence. J Adv Pract Oncol. May-June, 2014 5(3); 163-72
  • 2014 -- Schneider, S. M. and Adams, D. Strategies to improve adherence to oral chemotherapy agents. In Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook. edited by Gullatte, M. M.. March, 2014; : Oncology Nursing Society (ONS Press). March, 2014
  • 2014 -- PubMed # : 24480661 Hammelef, K. J. and Friese, C. R. and Breslin, T. M. and Riba, M. and Schneider, S. M. Implementing distress management guidelines in ambulatory oncology: a quality improvement project. Clin J Oncol Nurs. February, 2014 18 Suppl 31-6
  • 2013 -- PubMed # : 25032022 Trotter, K. and Schneider, S. M. and Turner, B. S. Group appointments in a breast cancer survivorship clinic. J Adv Pract Oncol. November-December, 2013 4(6); 423-31
  • 2013 -- PubMed # : 23697982 Prewitt, J. and Schneider, S. and Horvath, M. and Hammond, J. and Jackson, J. and Ginsberg, B. PCA Safety Data Review After Clinical Decision Support and Smart Pump Technology Implementation. J Patient Saf. June, 2013 9(2); 103-9
  • 2013 -- PubMed # : 23715708 Lowery, E. W. and Schneider, S. M. Ruxolitinib: a new treatment for myelofibrosis. Clin J Oncol Nurs. June, 2013 17(3); 312-8
  • 2013 -- PubMed # : 23051869 Chang, L. and Schneider, S. M. and Chiang, S. and Horng, C. Implementing an evidence-based risk assessment tool to predict chemotherapy-induced neutropenia in women with breast cancer. Cancer Nurs. May-June, 2013 36(3); 198-205

Pages

Grant Funding (Selected)

  • Tailored Adherence Protocol for Oral Chemotherapy

    National Institutes of Health/National Cancer Institute
    1R15-CA139398-01
    04/2009 to 03/2012
    Role: PI

    The aims of this study are to 1) test the effectiveness of a tailored protocol to promote adherence to oral chemotherapeutic agents in adults receiving treatment for breast or colorectal cancer, 2) examine adherence to oral chemotherapeutic agents over time, and 3) examine the effects of age, gender, caregiver availability, personal involvement in health care, and depression on adherence rates to oral chemotherapeutic agents. The tailored adherence protocol is based on the self-regulatory model of adherence. The intervention identifies patient knowledge, behavioral skills, and affective support and tailors adherence strategies or overcomes barriers in each of these three categories. A randomized clinical trial will examine the adherence rates in 150 adults started on a new oral chemotherapeutic agent at Duke University Medical Center. A control group will receive standard chemotherapy education. Participants in the experimental group will receive the standard education, an assessment and the tailored intervention developed by an advanced practice nurse. The intervention will be administered via telephone calls over six months. Patient adherence rates will be measured in both groups at 2, 4 and 6 months using self report, symptom profiles, and pharmacy fill rates.

  • Authorized Agent Controlled Analgesia (AACA) for PBMT

    Duke Translational Nursing Institute
    08/2010 to 08/2011
    Role: co-PI

    This project will demonstrate the feasibility of safely using AACA in the pediatric bone marrow transplant population who are six years old or younger and require analgesia for pain control with an adult, who completes the education and assessment required for AACA.

  • Tailored Adherence Protocol for Oral Chemotherapy

    DUSON Small Grant
    06/2008 to 05/2009
    Role: PI

    Project Goal: The aims of this pilot study are 1) to test the feasibility of administering a tailored protocol to promote adherence to oral chemotherapeutic agents in 20 adults receiving treatment for breast or colorectal cancer and 2) to measure adherence rates to oral chemotherapy in this sample.

  • Advanced Diabetes Management for Nurse Practitioners

    Health Resources and Service Administration (HRSA)
    1D09-HP08059-01-00
    07/2007 to 06/2010
    Role: PI

    Project Goal: Consistent with the legislation of Title VIII and in concert with the goals of Healthy People 2010 and National Goals I -III, the purpose of this new project is to prepare expert advanced practice nurses in the prevention and management of diabetes, particularly in high risk and underserved populations. We plan to use an innovative educative approach that allows those from rural areas to learn medical content regarding health problems that are highly prevalent in their communities, thus increasing the likelihood of graduated nurse practitioner students remaining in these communities to practice. The graduates of this program will be eligible for the American Nurses Credentialing Center (ANCC) exam as Adult or Family Nurse Practitioners. In addition, completion of the proposed Advanced Diabetes Management for Nurse Practitioners will provide students with the necessary didactic content to be eligible for the American Association of Diabetes Educators (AADE) exam to certify them as an Advanced Practitioner in Diabetes Management.

  • Polycystic Ovarian Syndrome: Impact of Flaxseed Supplementation

    Duke Clinical Research Unit
    D972
    07/2007 to 06/2009

    Duke Clinical Translational Science Award D972 by Grant Number 1UL1RR024128-01 from the National Center for Research Resources (NCCR).

  • Effect of Virtual Reality on Symptom Distress in Breast Cancer

    AACN Grant
    04/2006 to 03/2008
    Role: co-PI

    Project Goal: The purpose of this study was to examine the effects of a virtual reality distraction intervention on chemotherapy-related symptom distress levels in 54 women of all ages who were receiving chemotherapy for breast cancer.

  • Effect of Virtual Reality on Symptom Distress in Breast Cancer

    UNC Volunteer Association
    04/2006 to 03/2008
    Role: co-PI

    Project Goal: The purpose of this study was to examine the effects of a virtual reality distraction intervention on chemotherapy-related symptom distress levels in 54 women of all ages who were receiving chemotherapy for breast cancer.

  • Informal Caregiver Training in Cancer Symptom Management

    National Institute of Nursing Research
    1R15 NR009489-01A1
    03/2006 to 08/2008
    Role: Co-Investigator

    Project Goal: The purpose of this study is to examine the effects of experiential symptom management training on self-efficacy and psychological well-being of informal cancer caregivers, and on symptom distress and emergency care use for cancer-related symptoms of their patients.

  • Depression and Quality of Life in Patients with Gliomas

    Oncology Nursing Foundation
    04/2004 to 03/2006
    Role: Co-investigator

    Project Goal: To determine what demographic, diagnostic, or treatment variables are associated with the presence of depression or quality of life symptoms such as fatigue, appetite changes, sleep disturbances or sexual disturbances in adult patients with gliomas.

  • Virtual Reality for Chemotherapy Symptoms

    Oncology Nursing Society Foundation
    RE-12
    10/2002 to 11/2005
    Role: PI

    Project Goal: The purpose of this study is to determine the immediate and short-term (2 days) effects of a single virtual reality intervention on symptom distress levels in adults with lung, colon or breast cancer who are receiving intravenous chemotherapy.

Pages

Thursday, May 25, 2017

Two DNP alumni publish articles along with Susan Schneider in the June issue of Clinical Journal of Oncology Nursing.

Alumni Victoria Sherry and Schneider publish an article entitled "Metastatic Lung Cancer and Distress: Use of the Distress Thermometer for patient assessment." Other co-authors include experts from the University of Pennsylvania.

Tuesday, May 2, 2017

Susan Schneider was recently featured in a Medscape article entitled "Excitement Builds as ONS Congress Nears Opening Day." Schneider serves as the Oncology Nursing Society (ONS) president. The conference takes place in Denver, Colo. from May 4 to 7. Attendees can participate in discussions on diverse topics that advance patient care.

Click here to read full article.

Wednesday, January 25, 2017

DNP alumna Tracie Gadler and Susan Schneider publish an article entitled "The Effects of a Take-Home Educational Video on Patient Knowledge Retention, Anxiety, Satisfaction, and Provider Time" in the November/December issue of the Urologic Nursing. The project was completed as partial fulfillment for Gadler's DNP degree. Other co-authors include experts from Scripps Health in San Diego, CA, and Scripps Mercy in Chula Vista, CA.

Wednesday, October 19, 2016

Susan Schneider recently presented on "Nutritional Support in High Dose Chemotherapy Patients" and "Building Cancer Nursing Through National Societies" at the European Oncology Nursing Society Meeting in Dublin, Ireland.

Friday, October 7, 2016

Susan Schneider recently presented on "Every Nurse is a Leader: Invest in Your Future with Professional Development" at the Piedmont Triangle Oncology Nursing Society Meeting.

Friday, September 23, 2016

Susan Schneider presented on "International Perspectives on Cancer Survivorship" at the International Society of Nurses in Cancer Care in Hong Kong.

Friday, August 19, 2016

Susan Schneider presented on "Oncology Nursing Update: Oncology Nursing in Cuba" for the Tampa Oncology Nursing Society chapter at the Moffitt Cancer Center in Tampa, Florida.

Friday, July 1, 2016

Sue Schneider, in her role as Oncology Nursing Society (ONS) president, joined hundreds of health care leaders, patients, survivors and advocates for the National Cancer Moonshot Summit on June 2

Wednesday, May 25, 2016

We’ve all seen the Facebook or YouTube video of a person who has just completed cancer treatment and is overcome with joy, ringing the bell and sounding the alarm that treatment is done. What often moves us, in addition to the patient’s celebration, are the joyful and sometimes tearful faces of the oncology nurses.

Oncology nurses are at the forefront of cancer care every step of the way – in explaining the diagnosis, administering treatments, managing side effects, supporting patients and their families, rejoicing during triumphs and offering words of comfort.

Tuesday, May 24, 2016

Susan Schneider, PhD, RN, AOCN, FAAN, associate professor and faculty lead for the graduate oncology specialty at Duke University School of Nursing (DUSON), assumed the role of president of the Oncology Nursing Society (ONS) effective in April for a two-year term. Schneider was elected as president-elect last year for a one-year team.

Pages